Insider · CIK 0001229529

FLETCHER MARK

Reports to the SEC for 1 company · TORONTO ONTARIO CANADA, A1

sec.gov

Transactions

Companies

Filings

CIK

0001229529

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-10-03	GENEREX BIOTECHNOLOGY CORPStock Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+4,500 sh	—	—	4,500
2016-02-16	GENEREX BIOTECHNOLOGY CORPM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	+4.45M sh	$0.00	+$4,447.111	15,821,836
2016-02-16	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	−4.45M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	+14.9M sh	$0.00	+$14.9K	10,442,992
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	−1.46M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	−5.14M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	−1.59M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	+4.45M sh	—	—	4,447,111
2014-10-06	GENEREX BIOTECHNOLOGY CORPM Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	+471K sh	$0.00	+$470.726	470,726
2014-10-06	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (Right to Buy)M Exercise/Conversion	EVP General Counsel &Secretary	MExercise/Conversion	−471K sh	—	—	0
2013-10-31	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+2.25M sh	—	—	2,254,640
2013-06-06	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (Right to Buy)A Award	EVP General Counsel &Secretary	AAward	+1.59M sh	—	—	1,587,300
2013-04-01	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+5.14M sh	—	—	5,143,787
2012-06-19	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+1.46M sh	—	—	1,457,195
2011-04-06	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+20K sh	$0.24	+$4,780	286,077
2011-03-25	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+1.5M sh	—	—	1,500,000
2010-03-08	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+300K sh	—	—	300,000
2010-01-04	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+8,700 sh	$0.52	+$4,524	266,077
2009-11-13	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+10K sh	$0.49	+$4,900	257,377
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)D Disposition to Issuer	EVP General Counsel &Secretary	DDisposition to Issuer	−250K sh	—	—	0
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+250K sh	—	—	250,000
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)D Disposition to Issuer	EVP General Counsel &Secretary	DDisposition to Issuer	−471K sh	—	—	0
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	EVP General Counsel &Secretary	AAward	+470K sh	—	—	470,726
2009-01-12	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+10.2K sh	$0.32	+$3,250.88	245,177
2009-01-12	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+2,200 sh	$0.33	+$726	247,377
2008-10-31	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+500 sh	$0.37	+$185	210,518
2008-10-31	GENEREX BIOTECHNOLOGY CORPP Purchase	EVP General Counsel &Secretary	PPurchase	+24.5K sh	$0.38	+$9,310	235,018
2005-04-05	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionsA Award	EVP General Counsel &Secretary	AAward	+250K sh	—	—	250,000
2005-04-05	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionsA Award	EVP General Counsel &Secretary	AAward	+471K sh	—	—	470,726

Recent filings

Accepted (ET)
Oct 154
FLETCHER MARK0001607062-18-000347
SEC(opens sec.gov)
Feb 164
GENEREX BIOTECHNOLOGY CORP0001607062-16-000682
SEC(opens sec.gov)
Feb 124
GENEREX BIOTECHNOLOGY CORP0001607062-16-000653
SEC(opens sec.gov)
Oct 84
GENEREX BIOTECHNOLOGY CORP0001363585-14-000003
SEC(opens sec.gov)
Nov 14
GENEREX BIOTECHNOLOGY CORP0001554795-13-000649
SEC(opens sec.gov)
Jun 104
GENEREX BIOTECHNOLOGY CORP0001363585-13-000008
SEC(opens sec.gov)
Apr 14
GENEREX BIOTECHNOLOGY CORP0001363585-13-000007
SEC(opens sec.gov)
Jun 214
GENEREX BIOTECHNOLOGY CORP0001363585-12-000003
SEC(opens sec.gov)
Apr 254
GENEREX BIOTECHNOLOGY CORP0001144204-11-023823
SEC(opens sec.gov)
Apr 74
GENEREX BIOTECHNOLOGY CORP0001144204-11-020631
SEC(opens sec.gov)
Mar 104
GENEREX BIOTECHNOLOGY CORP0001144204-10-012520
SEC(opens sec.gov)

Companies

GENEREX BIOTECHNOLOGY CORPEVP General Counsel &Secretary

Address

33 HARBOUR SQUARE SUITE 102

TORONTO ONTARIO CANADA, A1, M5J2G2